Health Condition 1: I832- Varicose veins of lower extremities with both ulcer and inflammation
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patients willing to sign informed consent form and willing to participate in the study. 2. Patients diagnosed with varicose veins. 3. Patients with a clear history of prior treatment of the varicose veins. 4. Patients who have recurrent perforator as identified by ultrasound. 5. Patients belonging to C3 to C6 classes of the CEAP Classification.
Exclusion criteria
Exclusion criteria: 1. Patients with deep vein thrombosis. 2. Pregnant and lactating women. 3. Patients with immunocompromised status and terminal illness like cancer. 4. Patients with known allergy to cyanoacrylate adhesive. 5. Patients on treatment with anticoagulants or having any coagulopathy. 6. Patients not ready to consent to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To compare the closure rates of incompetent perforators at 6 month & 1 year post-procedure, as confirmed via Doppler ultrasound. - To assess improvement in clinical symptoms using the Venous Clinical Severity Score (VCSS) at 6 month and 1 year.Timepoint: 6 month and 1 year. | — |
Secondary
| Measure | Time frame |
|---|---|
| - To analyze the incidence of complications (immediate, at 6 month, and at 1 year) following each treatment modality. - To compare the average procedure time between n-butyl cyanoacrylate glue and endovenous laser ablation.Timepoint: Immediate, 6 month & 1 year | — |
Countries
India
Contacts
Datta Meghe Institute of Higher Education and Research (Deemed to be University)